Evidence map›Paper›PMID 15789162›Full record

ReviewJournal of immigrant health2005

Paan and Gutka in the United States: an emerging threat.

Jyotsna Changrani, Francesca Gany

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of immigrant health, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Betel Quid Use and Oral Cancer in a High-Risk Refugee Community in the USA: The Effectiveness of an Awareness Initiative.Journal of cancer education : the official journal of the American Association for Cancer Education · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Smokeless tobacco (Epidemiology and health · 2017
    Review
  17. Article
  18. Article
  19. Toxicity of gutkha, a smokeless tobacco product gone global: is there more to the toxicity than nicotine?International journal of environmental research and public health · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jyotsna ChangraniCenter for Immigrant Health, New York University School of Medicine, New York, New York 10016, USA. Jyotsna@med.nyu.edu
Francesca Gany

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smokeless tobacco and areca nut usage are integral cultural traditions in South Asia. Paan and gutka are two commonly used products which contain these ingredients. They are immensely popular in South Asia and with South Asian immigrants. Regular paan and gutka use is associated with several deleterious health consequences, most significantly oral cancer. Of particular concern is the markedly increased risk of oral cancer in South Asian immigrants when compared with the natives in new areas of settlement. The South Asian community in the United States is large and rapidly growing. Paan and gutka are legal in the United States, and readily available in ethnic enclaves. Smokeless tobacco prevention and cessation research and interventions have not yet addressed the unique sociocultural circumstances of this growing, at-risk community. The medical, dental, and public health communities need to join forces to combat this emerging threat.

Indexed as

ArecaAsia, SoutheasternAttitude to HealthCultural CharacteristicsEmigration and ImmigrationHealth EducationHumansMouth NeoplasmsPrimary PreventionRisk FactorsTobacco, SmokelessUnited States

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.